KURE vs OZEM

KraneShares MSCI All China Health Care Index ETF against Roundhill GLP-1 & Weight Loss ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
9%
3 shared positions
Fee gap
6 bp
OZEM is cheaper
1-year return gap
14.0 pts
OZEM is ahead
Larger fund
KURE
$110M

Side by side

KUREOZEM
FundKraneShares MSCI All China Health Care Index ETFRoundhill GLP-1 & Weight Loss ETF
IssuerKraneSharesRoundhill
CategorySingle CountryBiotech & Health Innovation
Expense ratio0.65%0.59%
Assets$110M$55M
Average daily dollar volume$1.5M$493K
ListedJan 31, 2018May 20, 2024
FrenzyCap score3833
1-month return+5.2%−5.9%
3-month return+11.0%−9.6%
Year to date+9.9%−13.3%
1-year return−12.6%+1.4%
30-day volatility29.4%20.4%
Worst drawdown, 1 year−29.7%−20.9%
Trailing 12-month yield3.82%1.39%
Holdings6326
Top 10 weight53.9%65.9%
Look-through P/E——
Holdings vs fair value—+3.2%
Holdings above 200-day average—54%
Net flow, latest 3 reported months−$3.3M thru Jun 2026+$286K thru Jun 2026
30-day implied volatility51.2%36.5%
Holdings as ofas of Jun 30, 2026SEC filingas of Jun 30, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

15% of KURE · 10% of OZEM
HoldingKUREOZEM
CSPC PHARMACEUTICAL GROUP LIMITED3.68%5.32%
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED2.85%2.54%
INNOVENT BIOLOGICS, INC.8.80%2.37%

Sector mix of the stock holdings

SectorKUREOZEMGap
Health Care1.3%57.2%−55.9%

More: full overlap table · KURE holdings · OZEM holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.